CERTIFICATE UNDER REGULATION 74(5) OF THE SEBI (DEPOSITORIES AND PARTICIPANTS) REGULATIONS, 2018 FOR THE QUARTER ENDED JUNE 30, 2024.

STATEMENT OF INVESTOR GRIEVANCES AS REQUIRED UNDER REGULATION 13(3) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATION, 2015 FOR THE QUARTER ENDED JUNE 30, 2024.

Disclosure under Regulation 30(2) of SEBI (LODR) for execution of Distributor Agreement.

Non Applicability of Corporate Governance.

Intimation of Acquisition of 51% stake in the Equity Share Capital of Saarathi Healthcare Private Limited.

Intimation for Amendment in Share Purchase Agreement with Saarathi Healthcare Private Limited.

Intimation of Investor call to be held on July 03, 2024.

Intimation for Closure of Trading Window for the first quarter ended June 30, 2024.

Intimation of Investor call to be held on June 22, 2024.

Outcome of Board Meeting held on June 06, 2024.